156 related articles for article (PubMed ID: 4035229)
1. [LDL-apheresis in the treatment of familial hypercholesterolemia].
Scarpato N; Postiglione A
Ric Clin Lab; 1985; 15 Suppl 1():499-504. PubMed ID: 4035229
[TBL] [Abstract][Full Text] [Related]
2. [Serum lipoprotein (a) levels during treatment with LDL apheresis for homozygous familial hypercholesterolemia].
Lasunción MA; Teruel JL; Alvarez JJ; Gómez-Coronado D; Ortuño J; Herrera E
Med Clin (Barc); 1992 Oct; 99(14):541-4. PubMed ID: 1434990
[TBL] [Abstract][Full Text] [Related]
3. [An apheresis method in treatment of familial hypercholesterolemia].
Derfler K
Wien Klin Wochenschr; 2000 Jan; 112(2):49-51. PubMed ID: 10703150
[No Abstract] [Full Text] [Related]
4. Plasmapheresis in familial hypercholesterolemia.
Thompson GR; Barbir M; Okabayashi K; Trayner I; Larkin S
Arteriosclerosis; 1989; 9(1 Suppl):I152-7. PubMed ID: 2912429
[TBL] [Abstract][Full Text] [Related]
5. [LDL-apheresis: current status].
Stefanutti C; Vivenzio A; Lucani G; Di Giacomo S
Clin Ter; 2001; 152(1):65-9. PubMed ID: 11382172
[TBL] [Abstract][Full Text] [Related]
6. From plasma-exchange to LDL-apheresis: new developments in the treatment of familial hypercholesterolemia.
Postiglione A; Gnasso A; Mastranzo P; Montefusco S; Motti C; Gallotta G; Cortese C; Scarpato N
Beitr Infusionsther; 1988; 23():74-80. PubMed ID: 2484784
[No Abstract] [Full Text] [Related]
7. Acute effects of LDL-apheresis on cholesterol oxidation products and antioxidants in plasma and lipoproteins of patients with familial hypercholesterolemia.
Linseisen J; Wilhelm M; Hoffmann J; Hailer S; Keller C; Wolfram G
Eur J Med Res; 1999 Oct; 4(10):433-41. PubMed ID: 10527957
[TBL] [Abstract][Full Text] [Related]
8. [Extracorporeal elimination of LDL-cholesterol in the treatment of hypercholesterolemia: indications and methods].
Bláha V; Havel E; Zadák Z; Pidrman V; Bláha M; Kalinová M
Vnitr Lek; 1995 Oct; 41(10):724-9. PubMed ID: 8578708
[TBL] [Abstract][Full Text] [Related]
9. [LDL apheresis--an effective treatment of homozygous familial hypercholesterolemia].
Kauppinen-Mäkelin R; Koivisto V; Virtanen KS; Taskinen MR; Miettinen T
Duodecim; 1990; 106(21):1465-70. PubMed ID: 1364677
[No Abstract] [Full Text] [Related]
10. Long-term effects of LDL apheresis in patients with severe hypercholesterolemia.
Sachais BS; Katz J; Ross J; Rader DJ
J Clin Apher; 2005 Dec; 20(4):252-5. PubMed ID: 15880364
[TBL] [Abstract][Full Text] [Related]
11. [Non-dietary, non-pharmacological treatment of severe hypercholesterolemia].
Hansen PS; Sølling J; Knudsen TE; Faergeman O
Ugeskr Laeger; 1991 Jul; 153(29):2046-51. PubMed ID: 1858184
[TBL] [Abstract][Full Text] [Related]
12. Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia.
Stefanutti C; Di Giacomo S; Vivenzio A; Isacchi GC; Masella R; Caprari P; Varì R; Tarzia A; Mosiello A; Cantafora A
Clin Sci (Lond); 2001 Feb; 100(2):191-8. PubMed ID: 11171288
[TBL] [Abstract][Full Text] [Related]
13. Lipidfiltration--safe and effective methodology to perform lipid-apheresis.
Klingel R; Mausfeld P; Fassbender C; Goehlen B
Transfus Apher Sci; 2004 Jun; 30(3):245-54. PubMed ID: 15172630
[TBL] [Abstract][Full Text] [Related]
14. Plasma exchange and LDL apheresis.
Thompson GR; Okabayashi K
Prog Clin Biol Res; 1988; 255():311-6. PubMed ID: 3277202
[No Abstract] [Full Text] [Related]
15. Direct adsorption of lipoproteins (DALI) from whole blood: first long-term clinical experience with a new LDL-apheresis system for the treatment of familial hypercholesterolaemia.
Jansen M; Banyai S; Schmaldienst S; Goldammer A; Rohac M; Hörl WH; Derfler K
Wien Klin Wochenschr; 2000 Jan; 112(2):61-9. PubMed ID: 10703153
[TBL] [Abstract][Full Text] [Related]
16. Plasma-exchange therapy of homozygous familial hypercholesterolemia.
King ME; Breslow JL; Lees RS
N Engl J Med; 1980 Jun; 302(26):1457-9. PubMed ID: 7374711
[No Abstract] [Full Text] [Related]
17. Regression of coronary atherosclerosis and amelioration of renal function during LDL-immunoadsorption therapy in a renal transplant recipient.
Jansen M; Gabriel H; Banyai S; Pidlich J; Weidinger F; Hörl WH; Derfler K
Wien Klin Wochenschr; 1996; 108(14):425-31. PubMed ID: 8784984
[TBL] [Abstract][Full Text] [Related]
18. Quantitative ultrastructural study of platelet plasma-membrane in hypercholesterolemic type IIa patients after plasma exchange and LDL-apheresis.
Bianciardi G; Gnasso A; Postiglione A; Scarpato N; Tanganelli P; Weber G
Beitr Infusionsther; 1988; 23():183-8. PubMed ID: 2484775
[No Abstract] [Full Text] [Related]
19. [Biological efficacy of LDL apheresis in major hypercholesterolemia].
Dairou F; Assogba U; Bruckert E; De Gennes JL; Turpin G
Ann Med Interne (Paris); 1994; 145(5):328-32. PubMed ID: 7985942
[TBL] [Abstract][Full Text] [Related]
20. [LDL oxidation in homozygous familial hypercholesterolemia: effects of selective LDL-apheresis treatment].
Napoli C; Postiglione A; Scarpato N; Corso G; Ambrosio G; Condorelli M; Mancini M; Chiariello M
Cardiologia; 1996 May; 41(5):435-9. PubMed ID: 8767632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
